Samsung Biologics 1. Juni 2026 Samsung creates ₩200 bil. fund to invest in global biotech ventures - koreabiomed.com
FierceBiotech 1. Juni 2026 Lilly pens $1.2B deal for Hanmi’s GLP-2 drug being aimed at short bowel syndrome
10x Genomics Blog 1. Juni 2026 10x Genomics CEO Sells Nearly 30,000 Shares. Here's What That Means for Investors. - The Motley Fool
WuXi Biologics 1. Juni 2026 BRIEF: WuXi Biologics maintains full-year revenue guidance for up to 17% growth - thebambooworks.com
Revvity 1. Juni 2026 Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers - TradingView
Agilent 1. Juni 2026 StockWatch: Agilent Shares Jump on Better than Expected Quarterly Results - Genetic Engineering and Biotechnology News
eLife 1. Juni 2026 Mural cells protect the adult brain from hemorrhage but do not control the blood–brain barrier in developing zebrafish
eLife 1. Juni 2026 Interplay between cohesin and TORC1 links chromosome segregation and gene expression to environmental changes
eLife 1. Juni 2026 Distinct evolutionary trajectories of two integration centres, the central complex and mushroom bodies, across Heliconiini butterflies
eLife 1. Juni 2026 Beta-Glucan modulates monocyte plasticity and differentiation capacity to mitigate DSS-induced colitis
FierceBiotech 31. Mai 2026 ASCO: Lilly exec points to ‘nutty’ 100% response rate for in vivo CAR-T as justifying Kelonia buyout
FierceBiotech 31. Mai 2026 ASCO: Revolution Medicines confident in RAS leadership as rivals square up
FierceBiotech 31. Mai 2026 ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%